Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Multimodal Analgesia and ERAS Protocol on Length of Hospital Stay After Laparoscopic Gynecological Surgeries
NCT07116564Phase 4Recruiting
- Sponsor
- Aga Khan University
- Start
- Aug 2025
- Primary completion
- Aug 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of celecoxib, Lidocaine Hydrochloride Injection, without epinephrine and fentanyl in gynecological disorders (2 arms), sponsored by Aga Khan University. Primary endpoint: Length of hospital stay at 72 hours. Started Aug 2025; status: recruiting.
02
Drugs
celecoxibLidocaine Hydrochloride Injection, without epinephrinefentanyl
03
Conditions
gynecological disorders
Beyond the preview
Go deeper on NCT07116564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07116564.